The Burnham Institute for Medical Research
| Award Total: $12,617,285 | # of Grants: 40 |
Investigators
HudsonFreezePh.D. - Li-TaoZhongM.D., Ph.D. - StevenFrischPh.D. - Xiao-KunZhangPh.D. - ZhihuaXiePh.D. - ShahrzadNourainiPh.D. - WadihArapM.D., Ph.D. - ShiHuangPh.D. - Xiao-KunZhangPh.D. - YoshinoriKohwiPh.D. - AdrienneCoxPh.D. - LawrenceQuilliam - ErkkiRuoslahtiM.D., Ph.D. - MagnusPfahlPh.D. - JeffreySmithPh.D. - ErkkiRuoslahtiM.D., Ph.D. - GeorgeSteele-PerkinsPh.D. - YoungsooKimPh.D. - ErkkiRuoslahtiM.D., Ph.D. - Shu-ichiMatsuzawaPh.D. - Iande BellePh.D. - KristiinaVuoriM.D., Ph.D. - TaroKawaiPh.D. - JeffreySmithPh.D. - Xiao-KunZhangPh.D. - SivaKolluriPh.D. - KristiinaVuoriM.D., Ph.D. - Xiao-KunZhangPh.D. - JohnReedM.D., Ph.D. - KristiinaVuoriM.D., Ph.D. - HuZhouPh.D. - WilliamStallcupPh.D. - PauloGodoiPh.D. - RenataSanoPhD - ElenaPasqualePh.D. - Tsung-HsienChuangPh.D. - WandaReynoldsPh.D. - NabilArrachPh.D. - CharlesSpruckPh.D. - ErikaLisabethPh.D. - Ying ChenHouPh.D - NicholasCosfordPh.D. -
Grants
| mGlu7 activators as drug candidates for nicotine dependence | 2016 (Cycle 25) | $481,721 |
| Neuroscience of Nicotine Addiction and Treatment | High Impact Pilot Award | |
| Metabolic stress & cell survival in lung cancer | 2012 (Cycle 21) | $89,208 |
| Early Diagnosis/Pathogenesis | Postdoctoral Fellowship Awards | |
| Mapping the EphA Receptor Landscape in Lung Cancer | 2011 (Cycle 20) | $98,299 |
| Cancer | Postdoctoral Fellowship Awards | |
| Fbxo2: a master regulator of lung cancer metastasis? | 2010 (Cycle 19) | $477,500 |
| Cancer | Exploratory/Developmental Award | |
| Engineering Salmonella for lung cancer therapy | 2007 (Cycle 16) | $104,050 |
| Cancer | New Investigator Awards | |
| Impact of MPO in Tobacco-related Cardiovascular Disease | 2007 (Cycle 16) | $267,555 |
| Cardiovascular Disease | Research Project Awards | |
| Modulating TLR9 Activation for Lung Cancer Therapy | 2007 (Cycle 16) | $415,463 |
| Cancer | Research Project Awards | |
| Role of EphA3 receptor mutations in lung cancer | 2009 (Cycle 18) | $477,500 |
| Cancer | Exploratory/Developmental Award | |
| Control of cellular self-digestion in lung tumorigenesis | 2009 (Cycle 18) | $135,000 |
| Cancer | Postdoctoral Fellowship Awards | |
| Targeting anti-apoptotic Bcl-2 family members in lung cancer | 2007 (Cycle 16) | $75,000 |
| Cancer | Postdoctoral Fellowship Awards | |
| Nicotine-dependent recruitment of vascular progenitor cells | 2006 (Cycle 15) | $799,907 |
| Cardiovascular Disease | Research Project Awards | |
| How omega-3 fatty acids prevent or slow cancer | 2006 (Cycle 15) | $74,808 |
| Cancer | Postdoctoral Fellowship Awards | |
| Novel Approaches to Lung Cancer Research | 2006 (Cycle 15) | $189,486 |
| Cancer | Inno Dev & Exp Awards (IDEAS) | |
| IAP Antagonists for lung cancer treatment | 2004 (Cycle 13) | $727,658 |
| Cancer | Research Project Awards | |
| Vitamin A derivatives as antagonists of nicotine effects | 2004 (Cycle 13) | $670,085 |
| Cancer | Research Project Awards | |
| Integrins and drug resistance in small cell lung cancer | 2003 (Cycle 12) | $780,144 |
| Cancer | Research Project Awards | |
| Targeting Hypoxia-inducible Factor to Treat Lung Cancer | 2003 (Cycle 12) | $509,490 |
| Cancer | New Investigator Awards | |
| Novel agents for apoptosis of lung cancer | 2002 (Cycle 11) | $787,977 |
| Cancer | Research Project Awards | |
| Smoking-induced oxidant stress & platelet integrin alpha.... | 2001 (Cycle 10) | $801,893 |
| Cardiovascular Disease | Research Project Awards | |
| ZIP kinase and lung cancer | 2001 (Cycle 10) | $65,854 |
| Cancer | Postdoctoral Fellowship Awards | |
| Overcoming drug resistance in small cell lung cancer | 2001 (Cycle 10) | $141,340 |
| Cancer | Inno Dev & Exp Awards (IDEAS) | |
| To identify Egr-1 target genes important in pulmonary disease | 2000 (Cycle 9) | $430,539 |
| Pulmonary Disease | New Investigator Awards | |
| Siah-family proteins in lung cancer | 2000 (Cycle 9) | $74,560 |
| Cancer | Postdoctoral Fellowship Awards | |
| Preneoplastic Lesions and Polarity Changes in Lung Epithelia | 1995 (Cycle 4) | $142,731 |
| Cancer | Inno Dev & Exp Awards (IDEAS) | |
| Function of Rb-interacting zinc-finger protein, "RIZ" | 1995 (Cycle 4) | $32,400 |
| Cancer | Postdoctoral Fellowship Awards | |
| Cell Adhesion Receptors in Atherogenesis | 1994 (Cycle 3) | $170,341 |
| Cardiovascular Disease | Research Project Awards | |
| The Role of TGF-B1 In Intimal Hyperplasia | 1994 (Cycle 3) | $66,448 |
| Cardiovascular Disease | Inno Dev & Exp Awards (IDEAS) | |
| Analysis of Retinoid Mediated Anti-cancer Activities | 1993 (Cycle 2) | $757,415 |
| Cancer | Research Project Awards | |
| Involvement of RAS and Krev-1 in Lung Cancer | 1993 (Cycle 2) | $50,552 |
| Cancer | Postdoctoral Fellowship Awards | |
| Ras Prenylation, Cholesterol Biosynthesis and Lung Cancer | 1993 (Cycle 2) | $49,960 |
| Cancer | Postdoctoral Fellowship Awards | |
| Studies in Genotoxicity of Tobacco-Related Carcinogens | 1992 (Cycle 1) | $288,000 |
| Cancer | New Investigator Awards | |
| Molecular Mechanism of Retinoic Acid Action | 1992 (Cycle 1) | $75,600 |
| General Biomedical Science | Postdoctoral Fellowship Awards | |
| Suppressor genes of lung cancer | 1998 (Cycle 7) | $859,254 |
| Cancer | Research Project Awards | |
| Toxic compounds targeted to lung tumor blood vessels | 1998 (Cycle 7) | $144,300 |
| Cancer | Inno Dev & Exp Awards (IDEAS) | |
| A study of Bax, a gene involved in killing tumor cells | 1998 (Cycle 7) | $75,060 |
| Cancer | Postdoctoral Fellowship Awards | |
| BAG-1, a unique gene involved in smoking-associated cancers | 1998 (Cycle 7) | $75,060 |
| Cancer | Postdoctoral Fellowship Awards | |
| Does nicotine inhibit anticancer activities of Vitamin A? | 1997 (Cycle 6) | $788,808 |
| Cancer | Research Project Awards | |
| A novel lung tumor suppressor | 1997 (Cycle 6) | $144,788 |
| Cancer | Inno Dev & Exp Awards (IDEAS) | |
| A novel therapeutic target for stroke | 1997 (Cycle 6) | $72,310 |
| Cardiovascular Disease | Postdoctoral Fellowship Awards | |
| 2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth | 1995 (Cycle 4) | $149,221 |
| Cardiovascular Disease | Inno Dev & Exp Awards (IDEAS) | |